STAT+: Conflicts among CDC and FDA vaccine panel members are not as numerous as you think, study finds
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
Conflicts of interest on federal government vaccine panels have declined to \u201chistorically low levels\u201d in recent years according to a new study, findings that are likely to increase debate over a contentious issue pushed by Health and Human Services Secretary Robert F. Kennedy Jr.<\/p>\n
The rate of conflicts among members of the Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices dropped from nearly 43% in 2000 to 5% last year, according to the study,<\/a> published Monday in JAMA. Conflicts on the Food and Drug Administration\u2019s Vaccines and Related Biological Products Advisory Committee fell from 11% to 0 during the same period.<\/p>\n Overall, the rate of any type of conflict declared by panel members was 13.5% on ACIP between 2000 and 2024, and 4% on the FDA vaccine panel, with conflicts dropping precipitously over the years on both panels. Most conflicts involved funding for research work \u2013 10% among ACIP panelists and nearly 1% on the FDA vaccine panel. Other types of conflicts \u2013 consulting, stock or patent ownership, and serving on a company data monitoring board \u2013 accounted for far fewer conflicts.<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n